Tenapanor in Hyperphosphatemia Is Effective but Has Cost, Market Barriers
Tenapanor offers a new approach to managing hyperphosphatemia in dialysis patients, balancing effectiveness with pill burden and cost considerations.
Acalabrutinib Demonstrates Improved Safety, Survival to Chemoimmunotherapy in CLL
Acalabrutinib shows improved safety and survival rates in chronic lymphocytic leukemia (CLL), reducing risks of mortality and cardiovascular complications.
BEAM-101 Receives RMAT for the Treatment of Sickle Cell Disease
The designation is supported by promising results from the ongoing phase 1/2 BEACON clinical trial.
Pharmacists’ Knowledge Gaps on Kratom: Building Competence for Patient Counseling
Pharmacists explore kratom’s potential benefits and risks, emphasizing the need for education on its effects, safety, and patient guidance.
Understanding FDA Terms for Possible New Therapies to Prevent and Treat Diseases
The FDA is responsible for protecting public health by ensuring the safety and effectiveness of drugs, biologics and medical devices.…
Patient Perceptions Support Co-Management of Chronic Kidney Disease
A collaborative care model enhances education and management for patients with chronic kidney disease, improving outcomes and understanding.
Research Underscores the Critical Role of Pharmacists in Managing Stiff Person Syndrome
Stiff Person Syndrome has unique complexities, necessitating the role of pharmacists in managing its symptoms and treatment options.
Overcoming Barriers in mCRC: Access, Adherence, and the Patient Voice
Panelists discuss how common barriers to implementing trifluridine/tipiracil plus bevacizumab combination therapy include complex pill burden management with multiple bottle…